Literature DB >> 18458299

Post-malaria neurological syndrome--two cases in patients of African origin.

Virginie Prendki1, Claire Elzière, Rémy Durand, Aicha Hamdi, Yves Cohen, Igor Onnen, Olivier Bouchaud.   

Abstract

Post-malaria neurological syndrome (PMNS) defined by a post-infective encephalopathy occurring within 2 months after an episode of Plasmodium falciparum infection is still a debated entity. We describe 2 cases of PMNS in 2 patients of African origin, born and living in France. Both patients had severe P. falciparum infection, followed by PMNS. They recovered with no sequelae. These are the first-reported cases of PMNS in patients of African ethnicity and living in France.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458299

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  1H NMR metabonomics indicates continued metabolic changes and sexual dimorphism post-parasite clearance in self-limiting murine malaria model.

Authors:  Arjun Sengupta; Soumita Ghosh; Shobhona Sharma; Haripalsingh M Sonawat
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

2.  Patient with post infective demyelinating disease for dynamic hip screw repair under epidural anaesthesia.

Authors:  Pritee H Bhirud; Dhanwanti Rajwade; Ragini Suchak
Journal:  Indian J Anaesth       Date:  2011-03

Review 3.  Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives.

Authors:  Remington L Nevin; Ashley M Croft
Journal:  Malar J       Date:  2016-06-22       Impact factor: 2.979

Review 4.  Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework.

Authors:  Yanis Tamzali; Sophie Demeret; Elie Haddad; Hélène Guillot; Eric Caumes; Stéphane Jauréguiberry
Journal:  Malar J       Date:  2018-10-26       Impact factor: 2.979

Review 5.  Post-malaria neurological syndrome: a rare neurological complication of malaria.

Authors:  Sanjay K Yadava; Ashley Laleker; Tasaduq Fazili
Journal:  Infection       Date:  2019-01-21       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.